|
| Forms of Products ： |
Synthetic pharmaceutical raw materials and intermediates |
| Capacity(year)： |
simvastatin |
36mt/year |
| Ciproflxacon Hcl |
400mt/year |
| Azithromycin |
180mt/year |
| Zisovudine |
12.5mt/year |
| CoQ10 |
5mt/year |
| Fleroxacin |
10mt/year |
| Troxerutin |
150mt/year |
Typical processes Available
| Acylation |
Fluorination |
| Alkylation |
Halogen Replacement |
| (De)bromination |
Halogenation |
| Bromomethylation |
Hydration |
| Chiral Synthasis |
Hydrogenation |
| Chloromethylation |
Hydroxylation |
| Chiorination |
(De)iodination |
| Cyclization |
Methylation |
| Decomoposition |
Oxidation |
| Dehalogenation |
Phase Transfer Reaction |
| Epoxidation |
Reduction |
| Esterification |
Ring-opening |
| (De)sulphonating |
|
|
|
|
|
